2014
DOI: 10.1016/j.drugalcdep.2014.02.702
|View full text |Cite
|
Sign up to set email alerts
|

Time to relapse following treatment for methamphetamine use: A long-term perspective on patterns and predictors

Abstract: Introduction This paper describes methamphetamine (MA) use patterns, specifically duration of continuing abstinence (“time to relapse”) for periods averaging 5 years post-discharge from treatment for MA use, and the relationship with selected user and treatment characteristics. Methods A sample of 350 treatment admissions from a large county substance use disorder (SUD) treatment system was randomly selected (within gender, race/ethnicity, treatment modality strata). Retrospective self-report data are from n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
151
1
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 210 publications
(159 citation statements)
references
References 76 publications
6
151
1
1
Order By: Relevance
“…Several studies examining drug-use severity, for example, have identified frequency of use at treatment entry to be an important factor that affects treatment response (Simpson et al, 2002;Vaillant, 1988). Recent studies with clinical samples of MAdependent users also support the importance of considering MA-severity when examining posttreatment outcomes, since heavy or daily use is considered to increase one's risk for relapse (Brecht and Herbeck, 2014;Elkashef et al, 2008Elkashef et al, , 2012Heinzerling et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Several studies examining drug-use severity, for example, have identified frequency of use at treatment entry to be an important factor that affects treatment response (Simpson et al, 2002;Vaillant, 1988). Recent studies with clinical samples of MAdependent users also support the importance of considering MA-severity when examining posttreatment outcomes, since heavy or daily use is considered to increase one's risk for relapse (Brecht and Herbeck, 2014;Elkashef et al, 2008Elkashef et al, , 2012Heinzerling et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…Medication studies, for example, have demonstrated that MA-dependent participants with lower baseline levels of MA use tend to have better outcomes (fewer MA-positive urine samples than those with higher baseline MA use (Elkashef et al, 2008;Heinzerling et al, 2014;Shoptaw et al, 2008). Similarly, in longitudinal outcome studies of MAdependent users (Brecht and Herbeck, 2014), lower MA severity at treatment admission serves as a strong predictor of posttreatment abstinence. Findings from these studies suggest that current clinical trial outcome studies for MA-dependence should consider the differential efficacy of experimental treatment regimens by MA use severity at treatment admission.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Since for methamphetamine a 1-year relapse rate of 61% and 10-year relapse rate of 77% (Brecht and Herbeck [12]) is reported, one could suggest that each year about 25 persons/100,000 inhabitants in this county may become dependent on methamphetamine.…”
Section: Discussionmentioning
confidence: 99%
“…Il est important de noter que cette étude excluait les personnes ayant des antécédents psychiatriques, voire un diagnostic actuel d'un trouble mental. Parmi les prédicteurs d'un taux de rechute plus faible au sein de personnes avec abus de MA cinq années après la fin de leur traitement, Brecht et Herbeck (2014) soulignent qu'avoir vécu des séquelles mentales importantes liées à la MA (ex. : psychose ou dépression), avoir participé à plus de sessions de traitement et avoir continué à rechercher du soutien ou des traitements à la fin du programme offert pré-disait une plus longue abstinence.…”
Section: Traitementunclassified